Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05867381
NA

Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History

Sponsor: University of Southern California

View on ClinicalTrials.gov

Summary

This double-blind, randomized, crossover trial aims to test the hypothesis that longer-term indoor air filtration intervention can slow atherothrombosis progression by reducing indoor fine particulate matter (PM2.5) exposure in adults with ischemic heart disease history.

Official title: Slowing Atherothrombosis Progression Through Indoor Air Filtration: A Crossover Trial in Hispanic and Non-Hispanic Adults With Ischemic Heart Disease History

Key Details

Gender

All

Age Range

65 Years - 84 Years

Study Type

INTERVENTIONAL

Enrollment

112

Start Date

2023-07-11

Completion Date

2027-06-30

Last Updated

2025-08-01

Healthy Volunteers

No

Interventions

DEVICE

HEPA filtration

HEPA filters with the capacity to reduce PM2.5 levels

DEVICE

Sham filtration

Sham filtration use the same appearance of air purifier but with HEPA filter removed.

Locations (1)

Keck School of Medicine, University of Southern California

Los Angeles, California, United States